Celldex Therapeutics to Present at the Cantor Fitzgerald Inaugural Healthcare Conference

HAMPTON, N.J., July 2, 2015 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX) announced today that Tibor Keler, Ph.D., Executive Vice President and Chief Scientific Officer, will present a corporate overview at the Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 at 8:30 a.m. EDT in New York City.

The live webcast of the presentation will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentation will be available for seven days following the event.

About Celldex Therapeutics, Inc.

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.            

CONTACT: Company Contact:
         Sarah Cavanaugh, Vice President of Investor Relations
         & Corp Communications
         Celldex Therapeutics, Inc.
         (781) 433-3161
         [email protected]

Source: Celldex Therapeutics, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Pixalate Releases Top 10 Apple TV Connected TV (CTV) Ad Fraud Types in Q1 2024: ‘Bundle ID’ Spoofing is No. 1 Fraud Type, Accounts for 43% of Invalid Traffic (IVT)
• Comcast Remains Dedicated to Closing the Digital Divide
• CHICKEN SALAD CHICK EXPANDS FOOTPRINT IN MISSISSIPPI WITH OPENING OF RIDGELAND RESTAURANT